Alitair Pharmaceuticals
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
99 Derby St Ste 200, Hingham, Massachuse...Phone Number
(877) 388-1464Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Alitair Pharmaceuticals
Alitair Pharmaceuticals is focused on developing innovative therapies for respiratory diseases, particularly through non-narcotic prescription cough medicines and treatments for bronchiectasis in both non-cystic fibrosis and cystic fibrosis patients. The company aims to address unmet medical needs by collaborating with strategic partners to commercialize its orphan drug portfolio and unique formulation-based intellectual property. Alitair is committed to building long-term relationships with partners to enhance patient care and create value for stakeholders. Their mission is to help patients living with respiratory diseases breathe easier.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Alitair Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Alitair Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Alitair Pharmaceuticals launches new products
Check out if Alitair Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Alitair Pharmaceuticals
Check if Alitair Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Alitair Pharmaceuticals recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Alitair Pharmaceuticals has new funding data
Alitair Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Alitair Pharmaceuticals
Find 2 more new buyers
Compare Similar Companies to Alitair Pharmaceuticals
Compare insights from companies similar to Alitair Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Alitair Pharmaceuticals
<$5M
1-10
Private
<$5M
2010
N/A
Company Profile Activity
Activity Insights
Alitair Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Alitair Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Alitair Pharmaceuticals.
Alitair Pharmaceuticals financials insights
Gather financial insights about Alitair Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$910K
Alitair Pharmaceuticals Tech Stack
A closer look at the technologies used by Alitair Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alitair Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Alitair Pharmaceuticals is focused on developing innovative therapies for respiratory diseases, particularly through non-narcotic prescription cough medicines and treatments for bronchiectasis in both non-cystic fibrosis and cystic fibrosis patients. The company aims to address unmet medical needs by collaborating with strategic partners to commerc... Read More
